Evaluation of Breast Cancer Screening Program at Assiut Governorate

NCT06403917 | Not Yet Recruiting

• 1 other identifier: Evaluation of BC program
• Study Type: observational
• Target: 15,000,000
• Locations: 0 countries
• Sites: N/A

Brief Summary

1. 1.To evaluate the ability of breast clinical examination as screening tool to detect early and advanced stages of breast cancer.
2. 2.To determine the percentage of breast cancer confirmed cases among women screened at women health campaign in Assiut governorate.
3. 3.To determine drop out from referral system among screening program.
4. 4.Identify the healthcare providers knowledge about breast cancer and screening tools, perception, practice and barriers in delivering the program

Conditions

Breast Cancer

Outcome Measures

Primary Outcomes (1)

• 1-To evaluate the ability of breast clinical examination as screening tool to detect early and advanced stages of breast cancer.

  1. Retention rate The estimated percentage of women above18 y who returned for screening within 12months % 2. Annual screening rate:The estimated percentage % of women above18 y who returned to screen within 18 months of their previous screen.

  one year

Secondary Outcomes (1)

• 2-To determine the percentage of breast cancer confirmed cases among women screened at women health campaign in Assiut governorate

  one year

Interventions

Evaluation of breast screening OTHER

Evaluation of breast screening program at egyptian women health intiaive

Eligibility Criteria

• Age: 18 Years - 73 Years
• Gender Eligibility Details: females above18
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

women coming to breast screening program at assiut governorate

You may qualify if:

• Primary health care units providing breast cancer screening service at Assiut governorate will be stratified in to rural, urban units. Two rural and two urban units will be randomly selected. Women at each unit will be classified according to age into below 38 years and above 38 years. A proportionate sample will be taken from each group.

Sponsors & Collaborators

• Assiut University: lead

Related Publications (1)

• Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011 Oct 22;378(9801):1461-84. doi: 10.1016/S0140-6736(11)61351-2. Epub 2011 Sep 14.

  PMID: 21924486 BACKGROUND

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Faten Rabie, PHD

  Assiut University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Hala Esaa, MD

CONTACT

+201091804647; hala.bahaa2021@gmail.com

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: dr halaa saad essa

Study Record Dates

• First Submitted: April 27, 2024
• First Posted: May 8, 2024
• Study Start: June 1, 2024
• Primary Completion: May 30, 2025
• Study Completion: May 30, 2025
• Last Updated: May 8, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share